Therapeutic Solutions International Inc. logo

Therapeutic Solutions International Inc. (TSOI)

Market Open
11 Aug, 20:00
OTC PINK OTC PINK
$
0. 00
0
0%
$
512.27K Market Cap
- P/E Ratio
- Div Yield
262,500 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track TSOI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

TSOI trading today higher at $0, an increase of 0% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, TSOI stock gained 0%.
TSOI is not paying dividends to its shareholders.
The last earnings report, released on May 28, 2025, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

TSOI Chart

People also search for

Decker Manufacturing Corporation
$ 57.01
0%
Cannabix Technologies Inc.
$ 0.39
-0.3284%
VicapSys Life Sciences Inc.
$ 1.45
0%
Nuo Therapeutics Inc.
$ 0.85
0%
Quantumzyme Corp.
$ 0.8
+33.3333%

Therapeutic Solutions International Inc. (TSOI) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Therapeutic Solutions International Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is TSOI.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 512.27K.

Has Therapeutic Solutions International Inc. ever had a stock split?

No, there has never been a stock split.

Therapeutic Solutions International Inc. Profile

Biotechnology Industry
Healthcare Sector
Timothy George Dixon CEO
OTC PINK Exchange
883378101 CUSIP
US Country
3 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Therapeutic Solutions International, Inc. is a company dedicated to the development of innovative treatments aimed at modulating the immune system to target specific diseases. Since its establishment in 2007 and based in Elk City, Idaho, the company has been focusing on creating a wide array of immune-modulatory agents. These are designed to tackle cancers, schizophrenia, suicidal ideation, traumatic brain injury (TBI), lung pathologies, and general health maintenance. Through its commitment to research and development, Therapeutic Solutions International aims to pioneer groundbreaking therapies that can significantly enhance patient health and recovery.

Products and Services

  • QuadraMune: A patented synergistic formula composed of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone designed to enhance natural killer cell activity and stimulate healthy cytokine production. This product embodies the company’s approach to boost immune function naturally.
  • ProJuvenol: A capsule-based nutraceutical that integrates complex anti-aging ingredients. This product aims to provide a synergistic blend to combat the effects of aging at the cellular level, promoting overall health and longevity.
  • NanoStilbene: Offers a nanoemulsion of nanoparticle pterostilbene, enhancing its bioavailability and effectiveness. This advanced formulation ensures that the body can more easily absorb and utilize pterostilbene, maximizing its potential benefits.
  • DermalStilbene: A topical spray that delivers pterostilbene directly to the skin. This product leverages the antioxidant properties of pterostilbene to support skin health and protect against environmental stressors.
  • IsoStilbene: An injectable form of pterostilbene, designed for those requiring a more direct and potent administration method. This formulation seeks to offer rapid and effective delivery of its active component.
  • NeuroStilbene: An intranasal form of pterostilbene, created for targeted delivery to the brain. This product is designed to support cognitive functions and brain health, capitalizing on the nasal route for fast absorption.
  • NanoPlus: A combination of NanoStilbene and Nano Cannabidiol, aiming to deliver the synergistic benefits of both compounds. This blend is designed to amplify their anti-inflammatory and antioxidant effects.
  • Nano Cannabidiol: Provides a nanoparticle formulation of cannabidiol, increasing its absorption and efficacy. This product is aimed at leveraging the therapeutic properties of cannabidiol without the psychoactive effects.
  • NanoPSA: A blend of NanoStilbene and broccoli sprout extract, formulated to provide a potent combination that supports prostate health and cellular protection.
  • NLRP3 Trifecta: A two-product combo including one bottle of NanoPSA and one bottle of GTE-50 green tea extract, designed to offer a comprehensive approach to combating inflammation and supporting immune health.

Contact Information

Address: 701 Wild Rose Lane
Phone: 760 295 7208